↓ Skip to main content

Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing…

Overview of attention for article published in Clinical Drug Investigation, December 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
23 Mendeley
Title
Efficacy, Safety, and Tolerability of Pantoprazole Magnesium in the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease (GERD): A Prospective, Multicenter, Post-Marketing Observational Study
Published in
Clinical Drug Investigation, December 2013
DOI 10.1007/s40261-013-0135-4
Pubmed ID
Authors

José María Remes-Troche, Sergio Sobrino-Cossío, Julio César Soto-Pérez, Oscar Teramoto-Matsubara, Miguel Morales-Arámbula, Antonio Orozco-Gamiz, José Luis Tamayo de la Cuesta, Gualberto Mateos

Abstract

To improve proton pump inhibitor effects, pharmacological modifications have been developed such as the use of enantiomer molecules (e.g., S-omeprazole, S-pantoprazole, or dexlansoprazole), or addition of NaHCO3 (for an immediate release) or magnesium (with a lower absorption for a more sustained effect).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 17%
Student > Ph. D. Student 4 17%
Student > Master 4 17%
Student > Bachelor 3 13%
Researcher 3 13%
Other 5 22%
Readers by discipline Count As %
Medicine and Dentistry 14 61%
Psychology 2 9%
Economics, Econometrics and Finance 1 4%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Other 4 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2014.
All research outputs
#10,004,223
of 12,499,603 outputs
Outputs from Clinical Drug Investigation
#473
of 573 outputs
Outputs of similar age
#117,222
of 175,296 outputs
Outputs of similar age from Clinical Drug Investigation
#6
of 7 outputs
Altmetric has tracked 12,499,603 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 573 research outputs from this source. They receive a mean Attention Score of 4.2. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 175,296 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.